Straits Times Index
3,322.62 +14.72 (+0.45%) S&P 500
5,271.76 -35.25 (-0.66%) Dow
39,077.51 -593.53 (-1.50%) Nasdaq
16,754.64 -46.90 (-0.28%) Bitcoin USD
67,091.48 -2,458.16 (-3.53%) CMC Crypto 200
1,464.94 -37.72 (-2.51%)
MRNA Oct 2024 60.000 call
| Previous close | 44.40 |
| Open | 44.40 |
| Bid | 66.25 |
| Ask | 67.70 |
| Strike | 60.00 |
| Expiry date | 2024-10-18 |
| Day's range | 44.40 - 44.40 |
| Contract range | N/A |
| Volume | |
| Open interest | 4 |
ZacksVaccine Stocks Rise on Growing Threat of Bird Flu Infections
The Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE) to develop bird flu vaccines over increasing fears of widespread transmission of the infection.
Barrons.comModerna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Last year, Moderna began early-stage tests of a number of avian flu vaccines that target different strains of the virus.
Barrons.comCDC Confirms a Second Bird Flu Case in U.S. Dairy Worker. Vaccine Momentum Builds.
U.S. officials said Wednesday that a Michigan dairy worker had tested positive for avian influenza, the second known human case in the U.S. since the virus was detected in late March in cattle. The Centers for Disease Control and Prevention said that the patient only had eye symptoms, similar to the first known infected dairy worker, who developed conjunctivitis in Texas in March. The CDC said that it still considers the risk from the current outbreak to the general public to be low.
